{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:57Z","timestamp":1791461457706,"version":"4.3.4"},"reference-count":65,"publisher":"Impact Journals, LLC","issue":"56","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,10]]},"DOI":"10.18632\/oncotarget.20731","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T18:36:15Z","timestamp":1504895775000},"page":"95432-95449","source":"Crossref","is-referenced-by-count":42,"title":["Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?"],"prefix":"10.18632","volume":"8","author":[{"given":"Paola","family":"Cavalcante","sequence":"first","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Marcuzzo","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Franzi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Galbardi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Motta","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, ASST - Bergamo Est Ospedale Bolognini Seriate, 24068 Seriate Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ghislandi","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, ASST - Bergamo Est Ospedale Bolognini Seriate, 24068 Seriate Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Buzzi","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, ASST - Bergamo Est Ospedale Bolognini Seriate, 24068 Seriate Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Department of General Surgery, ASST - Bergamo Est Ospedale Bolognini Seriate, 24068 Seriate Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Novellino","sequence":"additional","affiliation":[{"name":"Department of General Surgery, ASST - Bergamo Est Ospedale Bolognini Seriate, 24068 Seriate Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Baggi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Conforti","sequence":"additional","affiliation":[{"name":"Unit of Sarcomas and Thymomas, European Institute of Oncology, 20136 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso Martino","family":"De Pas","sequence":"additional","affiliation":[{"name":"Unit of Sarcomas and Thymomas, European Institute of Oncology, 20136 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[{"name":"Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, 20136 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[{"name":"Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico \u201cCarlo Besta\u201d, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Tzartos","year":"2016","journal-title":"Nature reviews neurology"},{"key":"2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Le Panse","year":"2014","journal-title":"Journal of autoimmunity"},{"key":"3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Str\u00f6bel","year":"2013","journal-title":"Autoimmunity reviews"},{"key":"4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Nix","year":"2016","journal-title":"The New England journal of medicine"},{"key":"5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-510X(03)00087-X","article-title":"Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in nonthymomatous myasthenia gravis patients: remission after 6 years of follow-up","volume":"212","author":"Cornelio","year":"2003","journal-title":"Journal of the neurological sciences"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Maggi, Andreetta, Antozzi, Baggi, Bernasconi, Cavalcante, Cornelio, Muscolino, Novellino, Mantegazza. Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 on a 20-year experience. Journal of neuroimmunology. 2008; pp. 201\u2013202. 237-244.","DOI":"10.1016\/j.jneuroim.2008.07.012"},{"key":"7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejcts.2009.05.038","article-title":"Thymoma and thymic carcinoma","volume":"37","author":"Coloni","year":"2010","journal-title":"European journal of cardiothoracic surgery"},{"key":"8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicenter study","volume":"44","author":"Venuta","year":"2013","journal-title":"European journal of cardiothoracic surgery"},{"key":"9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Girard","year":"2016","journal-title":"Autoimmunity reviews"},{"key":"10","first-page":"119","article-title":"Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus","volume":"407","author":"M\u00fcller-Hermelink","year":"1985","journal-title":"Virchows Archiv A, Pathological anatomy and histology"},{"key":"11","first-page":"9","volume-title":"Histological typing of tumors of the thymus, World Health Organization, International Histological Classification of Tumors, second ed","author":"Sobin","year":"1999"},{"key":"12","first-page":"542e54","article-title":"Thymoma classification: current status and future trends","volume":"125","author":"Moran","year":"2006","journal-title":"American journal of clinical pathology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Marx","year":"2004","journal-title":"Journal of clinical oncology"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Okumura, Fujii, Shiono, Inoue, Minami, Utsumi, Kadota, Sawa. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. General thoracic and cardiovascular surgery. 2008; 56:143\u2013150.","DOI":"10.1007\/s11748-007-0185-8"},{"key":"15","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG: characteristic and long-term outcome","volume":"59","author":"Lauriola","year":"2002","journal-title":"Neurology"},{"key":"16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Weis","year":"2015","journal-title":"Experimental neurology"},{"key":"17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \u201cseronegative\u201d myasthenia gravis - A new role for an old antigen","volume":"292","author":"Vaknin","year":"2016","journal-title":"Journal of neuroimmunology"},{"key":"18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: On the search for a pathogen signature","volume":"52","author":"Le Panse","year":"2014","journal-title":"Journal of autoimmunity"},{"key":"19","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Hogquist","year":"2015","journal-title":"Clinical & translational immunology"},{"key":"20","first-page":"1602","article-title":"Epstein-Barr Virus: diseases linked to infection and transformation","volume":"7","author":"Robertson","year":"2016","journal-title":"Frontiers in microbiology"},{"key":"21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tim.2016.03.008","article-title":"Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers","volume":"24","author":"Pagano","year":"2016","journal-title":"Trends in microbiology"},{"key":"22","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/v4123701","article-title":"Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis\u2014association and causation","volume":"4","author":"Holm\u00f8y","year":"2012","journal-title":"Viruses"},{"key":"23","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"Middeldorp","year":"2011","journal-title":"Brain"},{"key":"24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Mantegazza","year":"2010","journal-title":"Annals of neurology"},{"key":"25","first-page":"213092","article-title":"Inflammation and Epstein-Barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis","volume":"2011","author":"Mantegazza","year":"2011","journal-title":"Autoimmune Diseases"},{"key":"26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection","volume":"221","author":"Giardina","year":"2016","journal-title":"Immunobiology"},{"key":"27","first-page":"385","article-title":"Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia","volume":"131","author":"Lee","year":"1988","journal-title":"American journal of pathology"},{"key":"28","first-page":"1429","article-title":"Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction","volume":"136","author":"Knowles","year":"1990","journal-title":"American journal of pathology"},{"key":"29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1034\/j.1600-0463.2000.d01-74.x","article-title":"Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA(EBER) in situ hybridization","volume":"108","author":"Engel","year":"2000","journal-title":"APMIS"},{"key":"30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/path.1141","article-title":"Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization","volume":"197","author":"Chiang","year":"2002","journal-title":"The journal of pathology"},{"key":"31","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/JCM.42.6.2850-2854.2004","article-title":"A case of Epstein-Barr Virus (EBV)-associated thymic carcinoid and investigation of existence of EBV-infected cells in thymus and thymic tumors","volume":"42","author":"Takahashi","year":"2004","journal-title":"Journal of clinical microbiology"},{"key":"32","first-page":"2338","article-title":"Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome","volume":"63","author":"Caroll","year":"2003","journal-title":"Cancer research"},{"key":"33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2014.10.030","article-title":"Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA","volume":"474","author":"Rowe","year":"2015","journal-title":"Virology"},{"key":"34","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/JVI.78.8.3941-3952.2004","article-title":"Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV","volume":"78","author":"Bornkamm","year":"2004","journal-title":"Journal of virology"},{"key":"35","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/JVI.01416-06","article-title":"Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes","volume":"81","author":"Takada","year":"2007","journal-title":"Journal of virology"},{"key":"36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Moser","year":"1998","journal-title":"The Journal of experimental medicine"},{"key":"37","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","article-title":"Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3","volume":"206","author":"Takada","year":"2009","journal-title":"The Journal of experimental medicine"},{"key":"38","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/cancers6031615","article-title":"Epstein-Barr virus-encoded RNAs: key molecules in viral pathogenesis","volume":"6","author":"Iwakiri","year":"2014","journal-title":"Cancers (Basel)"},{"key":"39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Akira","year":"2010","journal-title":"Nature immunology"},{"key":"40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Le Panse","year":"2013","journal-title":"Autoimmunity reviews"},{"key":"41","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Bernasconi","year":"2010","journal-title":"Neurology"},{"key":"42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00126334-200203010-00012","article-title":"Detection of HTLVI tax-rex and pol gene sequences of thymus gland in large group of patients with myasthenia gravis","volume":"29","author":"Angelini","year":"2002","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"43","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Graus","year":"2008","journal-title":"Brain"},{"key":"44","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2169\/internalmedicine.56.7979","article-title":"Thymoma-associated progressive encephalomyelitis with rigidity and myoclonus (PERM) with myasthenia gravis","volume":"56","author":"Kusaka","year":"2017","journal-title":"Internal medicine"},{"key":"45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/267052a0","article-title":"Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro","volume":"267","author":"Britton","year":"1977","journal-title":"Nature"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Frappier. Current topics in microbiology and immunology. 2015; 391:3\u201334.","DOI":"10.1007\/978-3-319-22834-1_1"},{"key":"47","first-page":"241","article-title":"B-cells in thymic epithelial tumours. An immunohistochemical analysis of intra- and extraepithelial B-cell compartments","volume":"63","author":"M\u00fcller-Hermelink","year":"1993","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1746-1596-2-13","article-title":"Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers","volume":"2","author":"Burke","year":"2007","journal-title":"Diagnostic pathology"},{"key":"49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2011.09.037","article-title":"Different molecular expression in thymoma with ocular or generalized myasthenia gravis","volume":"313","author":"Zhang","year":"2012","journal-title":"Journal of the neurological sciences"},{"key":"50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nature review immunology"},{"key":"51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Thorley-Lawson","year":"2000","journal-title":"Immunity"},{"key":"52","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death","volume":"65","author":"Rickinson","year":"1991","journal-title":"Cell"},{"key":"53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1759-7714.2010.00028.x","article-title":"Prognostic factors and genetic markers in thymoma","volume":"1","author":"Van Schil","year":"2010","journal-title":"Thoracic cancer"},{"key":"54","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","article-title":"EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching","volume":"171","author":"Cerutti","year":"2003","journal-title":"Journal of immunology"},{"key":"55","first-page":"1358","article-title":"A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis","volume":"65","author":"Simon","year":"2008","journal-title":"Archives of neurology"},{"key":"56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2006.05.023","article-title":"The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis","volume":"178","author":"Jonsson","year":"2006","journal-title":"Journal of neuroimmunology"},{"key":"57","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.177.5.2793","article-title":"EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity","volume":"177","author":"Clarke","year":"2006","journal-title":"Journal of immunology"},{"key":"58","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1099\/0022-1317-77-12-3077","article-title":"Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection","volume":"77","author":"Cooper","year":"1996","journal-title":"The Journal of general virology"},{"key":"59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2012.11.003","article-title":"The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis","volume":"256","author":"Yang","year":"2013","journal-title":"Journal of neuroimmunology"},{"key":"60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Le Panse","year":"2013","journal-title":"Annals of neurology"},{"key":"61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cavalcante","year":"2014","journal-title":"Journal of autoimmunity"},{"key":"62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0092-8674(88)90530-2","article-title":"Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line","volume":"52","author":"Singer","year":"1988","journal-title":"Cell"},{"key":"63","first-page":"923","article-title":"Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders","volume":"147","author":"Meijer","year":"1995","journal-title":"American journal of pathology"},{"key":"64","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/605610","article-title":"Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases","volume":"200","author":"Nishiyama","year":"2009","journal-title":"The Journal of infectious diseases"},{"key":"65","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"O'Connor","year":"2009","journal-title":"Brain"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T20:19:19Z","timestamp":1719433159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":65,"journal-issue":{"issue":"56","published-print":{"date-parts":[[2017,11,10]]}},"alternative-id":["20731","29221139"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20731","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]}}}